In focus · trending topic

skin diseases

45 stories · following the connections

Dermira Announces Proposed Offering of $250 Million of Convertible Senior Notes

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC

Dermira Announces Proposed Offering of $250 Million of Convertible Senior Notes

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC

Dermira Announces Proposed Offering of $250 Million of Convertible Senior Notes

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC

Dermira Reports First Quarter 2017 Financial Results and Provides Corporate Update

By Nasdaq OMXMay 8, 2017, 8:09 PM UTC

Dermira to Present at Needham 16th Annual Healthcare Conference

By Nasdaq OMXMar 28, 2017, 8:05 PM UTC

Galectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

By Nasdaq OMXMar 21, 2017, 12:30 PM UTC

Dermira Presents New Data Highlighting Patient Outcomes in Axillary Hyperhidrosis at Maui Derm Meeting

By Nasdaq OMXMar 21, 2017, 11:30 AM UTC

Dermira to Highlight Data for Three Clinical Programs at Annual Maui Derm Meeting

By Nasdaq OMXMar 17, 2017, 12:30 PM UTC